MPLX CEO Hennigan reports no sign of cancer after treatment

MPLX LP

CEO Michael Hennigan says tests show no sign of throat cancer following treatment.
Completed seven-week radiation and chemotherapy protocol a few months ago.
Prognosis is excellent; he will continue to be monitored as a routine precaution.
Hennigan remains Chairman, President and CEO and is focused on leading MPLX.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.